In this episode, we dive into the GLP-1 conversation that’s everywhere—between “miracle drug” hype, scary side-effect stories, and the stigma that comes with seeking help. We share the kind of patient scenario we’re seeing constantly, talk about why these meds went viral, and explore what often gets lost in online discourse: nuance, individualized risk/benefit decisions, and real informed consent. We also tease what we consider when someone has health anxiety, a history of disordered eating, or is getting information (or prescriptions) through less-regulated channels.

00:00 Podcast intro and mission
01:18 Patient story GLP-1 dilemma
03:23 Social media claims and stigma
06:29 Why GLP-1s went viral
12:06 Nugget of truth and nuance
13:51 What GLP-1 drugs are
17:57 Benefits beyond diabetes
23:57 Fatty liver and metabolism
28:37 Is weight loss a benefit
34:22 Weight Stigma in Care
35:53 When to Discuss Weight
37:46 Is Weight Loss a Benefit
39:05 BMI vs Metabolic Health
40:21 GLP-1 Weight Loss Data
43:31 Long-Term Outcomes Matter
44:53 Weight Cycling Risks
47:58 Other Potential Benefits
48:51 Common Side Effects
49:59 Muscle and Bone Loss
52:44 Cancer and Eye Concerns
56:13 Mental Health Signals
59:21 Telehealth Misuse Risks
01:02:45 Cost and Sustainability
01:05:23 Alternatives Like Metformin
01:06:29 Long-Term Treatment Reality
01:09:37 Undereating Risks
01:10:04 Early Intervention Debate
01:11:12 Biology Over Willpower
01:11:58 Environment Versus Meds
01:13:58 Weight Cycling Reality
01:15:31 Compounded GLP-1 Dangers
01:21:05 Informed Consent Lessons
01:22:42 Stigma and Patient Fears
01:27:08 Food Noise Explained
01:31:40 Fatphobia and Epigenetics
01:35:05 How We Counsel Patients
01:43:01 Resources and Disclaimer

📖 Read the full episode summary, sources, and resources on our Substack:
👉www.theantisocialdoctors.com

In this episode, we dig into peptides—why they’re suddenly everywhere, why people are trying them, and why the online conversation often feels worlds apart from the medical one. We zoom out from the hype to explore what peptides actually are, why some have become blockbuster therapies, and how a mix of optimization culture, mistrust of institutions, and access issues has fueled a booming gray market. We also explore the key questions we think everyone should be asking before trying anything that’s framed as “natural,” “risk-free,” or “not really a drug,” and we discuss what this trend can teach us about informed consent, patient autonomy, and where medicine may be headed next.

00:00 Podcast intro
01:18 Meet the hosts
01:21 Peptides topic setup
02:01 Patient longevity story
03:39 Why peptides hype
05:11 Natural fallacy talk
06:50 What is a peptide
08:19 Peptide drugs history
10:47 Why peptides booming
12:06 Legal gray areas
13:55 Why it went viral
14:50 Optimization culture
16:35 Distrust and marketing
20:14 K shaped economy angle
24:37 Nugget of truth
26:44 Peptides are drugs
28:56 Gray market risks
31:30 Evidence categories
32:49 FDA approved examples
33:22 Immune booster peptide
34:14 Growth Hormone Peptides
35:00 Side Effects Reality Check
36:49 Statins Versus Hype
37:54 Retatrutide Triple Agonist
38:59 Wolverine Stack Breakdown
39:31 BPC 157 Claims
40:35 TB 500 No Human Data
43:17 Regulation Versus Wild West
45:11 Why Patients Take Risks
46:42 Doctoring With Empathy
50:26 Informed Consent Gaps
52:55 Framing Changes Decisions
55:39 Peptides Future Outlook
58:26 Fund Studies Faster
01:00:05 Wrap Up And Disclaimer

📖 Read the full episode summary, sources, and resources on our Substack:
👉www.theantisocialdoctors.com

In this episode, we dive into the current obsession with protein—why it’s everywhere, why people feel pressure to hit high daily targets, and how even official messaging is fueling the conversation. We review what protein actually does, who may benefit from prioritizing it, why “more” isn’t always better, and how real-life constraints and the modern food environment may complicate the the outcomes of "eat more protein" messaging.

00:00 Podcast Mission Intro
01:19 Why Protein Is Everywhere
03:09 The Viral Protein Claim
04:24 How Protein Became Trendy
07:36 Optimization Culture and Inequality
10:45 New US Protein Guidelines
12:53 Protein Basics and Sarcopenia
15:02 Who Needs More Protein
16:10 How Much Americans Eat Now
18:54 Evidence Based Targets by Group
20:12 Lean Mass Caveat for Obesity
22:25 Why Protein Targets Creep Up
23:42 Who Actually Benefits
24:23 More Protein Without Training
26:39 Social Media Protein Hype
28:18 Plant Proteins Explained
29:57 Guidelines Graphic Critique
31:35 Protein Products and Marketing
33:39 When Supplements Make Sense
36:09 Barriers Beyond Willpower
37:33 Practical Takeaways and Trends
42:12 Resources and Wrap Up
42:48 Medical Disclaimer

📖 Read the full episode summary, sources, and resources on our Substack:
👉www.theantisocialdoctors.com